BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. FRESENIUS KABI USA, LLC et al
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
| FRESENIUS KABI USA, LLC and FRESENIUS KABI ONCOLOGY LTD. |
| FRESENIUS KABI USA, LLC and FRESENIUS KABI ONCOLOGY LTD. |
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH, BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. |
| 3:2018cv03244 |
| March 7, 2018 |
| US District Court for the District of New Jersey |
| Trenton Office |
| Mercer |
| Lois H. Goodman |
| Michael A. Shipp |
| Patent - Abbreviated New Drug Application |
| 15 U.S.C. ยง 1126 |
| None |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
